PPARG and polycystic ovary syndrome: It must be noted that, in addition, PPARγ signaling at the pituitary, the placenta and the ovary has been shown to participate in the control of female reproduction (99), and the use of PPARγ agonists has been proposed in the context of reproductive disorders bound to metabolic alterations, such as polycystic ovary syndrome.